• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于模型的精准医学优化方法:以突触前多巴胺活性过高为例的案例研究。

Model-based optimization approaches for precision medicine: A case study in presynaptic dopamine overactivity.

作者信息

Hsu Kai-Cheng, Wang Feng-Sheng

机构信息

Department of Neurology, National Taiwan University Hospital Yunlin Branch, Yunlin, Taiwan.

Department of Chemical Engineering, National Chung Cheng University, Chiayi, Taiwan.

出版信息

PLoS One. 2017 Jun 14;12(6):e0179575. doi: 10.1371/journal.pone.0179575. eCollection 2017.

DOI:10.1371/journal.pone.0179575
PMID:28614410
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5470743/
Abstract

Precision medicine considers an individual's unique physiological characteristics as strongly influential in disease vulnerability and in response to specific therapies. Predicting an individual's susceptibility to developing an illness, making an accurate diagnosis, maximizing therapeutic effects, and minimizing adverse effects for treatment are essential in precision medicine. We introduced model-based precision medicine optimization approaches, including pathogenesis, biomarker detection, and drug target discovery, for treating presynaptic dopamine overactivity. Three classes of one-hit and two-hit enzyme defects were detected as the causes of disease states by the optimization approach of pathogenesis. The cluster analysis and support vector machine was used to detect optimal biomarkers in order to discriminate the accurate etiology from three classes of disease states. Finally, the fuzzy decision-making method was employed to discover common and specific drug targets for each classified disease state. We observed that more accurate diagnoses achieved higher satisfaction grades and dosed fewer enzyme targets to treat the disease. Furthermore, satisfaction grades for common drugs were lower than for specific ones, but common drugs could simultaneously treat several disease states that had different etiologies.

摘要

精准医学认为个体独特的生理特征对疾病易感性和对特定治疗的反应有很大影响。在精准医学中,预测个体患疾病的易感性、做出准确诊断、最大化治疗效果以及最小化治疗的不良反应至关重要。我们引入了基于模型的精准医学优化方法,包括发病机制、生物标志物检测和药物靶点发现,用于治疗突触前多巴胺活性过高。通过发病机制优化方法检测到三类单基因和双基因酶缺陷是疾病状态的病因。使用聚类分析和支持向量机来检测最佳生物标志物,以便从三类疾病状态中辨别准确的病因。最后,采用模糊决策方法为每种分类的疾病状态发现共同和特定的药物靶点。我们观察到,更准确的诊断获得了更高的满意度等级,并且治疗疾病所需的酶靶点剂量更少。此外,常用药物的满意度等级低于特定药物,但常用药物可以同时治疗几种病因不同的疾病状态。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b290/5470743/8e4679e39a28/pone.0179575.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b290/5470743/f10a34e50dbd/pone.0179575.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b290/5470743/86074b7a6db1/pone.0179575.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b290/5470743/d9ef41535bb3/pone.0179575.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b290/5470743/b581f9feaca1/pone.0179575.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b290/5470743/8e4679e39a28/pone.0179575.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b290/5470743/f10a34e50dbd/pone.0179575.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b290/5470743/86074b7a6db1/pone.0179575.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b290/5470743/d9ef41535bb3/pone.0179575.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b290/5470743/b581f9feaca1/pone.0179575.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b290/5470743/8e4679e39a28/pone.0179575.g005.jpg

相似文献

1
Model-based optimization approaches for precision medicine: A case study in presynaptic dopamine overactivity.基于模型的精准医学优化方法:以突触前多巴胺活性过高为例的案例研究。
PLoS One. 2017 Jun 14;12(6):e0179575. doi: 10.1371/journal.pone.0179575. eCollection 2017.
2
Fuzzy Decision Making Approach to Identify Optimum Enzyme Targets and Drug Dosage for Remedying Presynaptic Dopamine Deficiency.用于确定纠正突触前多巴胺缺乏的最佳酶靶点和药物剂量的模糊决策方法
PLoS One. 2016 Oct 13;11(10):e0164589. doi: 10.1371/journal.pone.0164589. eCollection 2016.
3
Precision cancer medicine: where to target?精准癌症医学:靶向何处?
Acta Pharmacol Sin. 2015 Oct;36(10):1161-2. doi: 10.1038/aps.2015.93. Epub 2015 Sep 21.
4
Leveraging big data to transform target selection and drug discovery.利用大数据变革靶点选择与药物研发。
Clin Pharmacol Ther. 2016 Mar;99(3):285-97. doi: 10.1002/cpt.318.
5
Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives.临床蛋白质组学驱动的精准癌症靶向治疗:当前概述与未来展望
Expert Rev Proteomics. 2016;13(4):367-81. doi: 10.1586/14789450.2016.1159959. Epub 2016 Mar 16.
6
Automated Detection of Cancer Associated Genes Using a Combined Fuzzy-Rough-Set-Based F-Information and Water Swirl Algorithm of Human Gene Expression Data.基于模糊粗糙集的F信息与人类基因表达数据的水漩涡算法相结合自动检测癌症相关基因
PLoS One. 2016 Dec 9;11(12):e0167504. doi: 10.1371/journal.pone.0167504. eCollection 2016.
7
Patient classification and outcome prediction in IgA nephropathy.IgA肾病的患者分类与预后预测
Comput Biol Med. 2015 Nov 1;66:278-86. doi: 10.1016/j.compbiomed.2015.09.003. Epub 2015 Sep 25.
8
Long range personalized cancer treatment strategies incorporating evolutionary dynamics.结合进化动力学的远程个性化癌症治疗策略。
Biol Direct. 2016 Oct 22;11(1):56. doi: 10.1186/s13062-016-0153-2.
9
Five critical elements to ensure the precision medicine.确保精准医疗的五个关键要素。
Cancer Metastasis Rev. 2015 Jun;34(2):313-8. doi: 10.1007/s10555-015-9555-3.
10
Opportunities and challenges in phenotypic drug discovery: an industry perspective.表型药物发现的机遇与挑战:行业视角。
Nat Rev Drug Discov. 2017 Aug;16(8):531-543. doi: 10.1038/nrd.2017.111. Epub 2017 Jul 7.

引用本文的文献

1
Artificial intelligence and machine-learning approaches in structure and ligand-based discovery of drugs affecting central nervous system.基于结构和配体的影响中枢神经系统药物发现中的人工智能和机器学习方法
Mol Divers. 2023 Apr;27(2):959-985. doi: 10.1007/s11030-022-10489-3. Epub 2022 Jul 11.
2
Artificial intelligence and machine learning-aided drug discovery in central nervous system diseases: State-of-the-arts and future directions.人工智能和机器学习辅助中枢神经系统疾病药物发现:现状与未来方向。
Med Res Rev. 2021 May;41(3):1427-1473. doi: 10.1002/med.21764. Epub 2020 Dec 9.
3
Revolution in Health Care: How Will Data Science Impact Doctor-Patient Relationships?

本文引用的文献

1
Neurotransmitter systems, neuroanatomical pathology and cell death in schizophrenia: update and perspectives.
Invest Clin. 2016 Jun;57(2):217-230.
2
Fuzzy Decision Making Approach to Identify Optimum Enzyme Targets and Drug Dosage for Remedying Presynaptic Dopamine Deficiency.用于确定纠正突触前多巴胺缺乏的最佳酶靶点和药物剂量的模糊决策方法
PLoS One. 2016 Oct 13;11(10):e0164589. doi: 10.1371/journal.pone.0164589. eCollection 2016.
3
Emerging applications of metabolomics in drug discovery and precision medicine.代谢组学在药物发现和精准医学中的新兴应用。
医疗保健领域的革命:数据科学将如何影响医患关系?
Front Public Health. 2018 Apr 3;6:99. doi: 10.3389/fpubh.2018.00099. eCollection 2018.
Nat Rev Drug Discov. 2016 Jul;15(7):473-84. doi: 10.1038/nrd.2016.32. Epub 2016 Mar 11.
4
Computational oncology--mathematical modelling of drug regimens for precision medicine.计算肿瘤学——精准医学中药物方案的数学建模。
Nat Rev Clin Oncol. 2016 Apr;13(4):242-54. doi: 10.1038/nrclinonc.2015.204. Epub 2015 Nov 24.
5
Precision medicine--personalized, problematic, and promising.精准医学——个性化、存在问题且充满希望。
N Engl J Med. 2015 Jun 4;372(23):2229-34. doi: 10.1056/NEJMsb1503104. Epub 2015 May 27.
6
Precision medicine: Clarity for the clinical and biological complexity of Alzheimer's and Parkinson's diseases.精准医学:明晰阿尔茨海默病和帕金森病的临床与生物学复杂性
J Exp Med. 2015 May 4;212(5):601-5. doi: 10.1084/jem.20150656.
7
A new initiative on precision medicine.一项关于精准医学的新倡议。
N Engl J Med. 2015 Feb 26;372(9):793-5. doi: 10.1056/NEJMp1500523. Epub 2015 Jan 30.
8
CompareSVM: supervised, Support Vector Machine (SVM) inference of gene regularity networks.CompareSVM:监督式支持向量机(SVM)对基因调控网络的推断
BMC Bioinformatics. 2014 Nov 30;15(1):395. doi: 10.1186/s12859-014-0395-x.
9
Inflammation and the two-hit hypothesis of schizophrenia.炎症与精神分裂症的二次打击假说
Neurosci Biobehav Rev. 2014 Jan;38:72-93. doi: 10.1016/j.neubiorev.2013.11.006. Epub 2013 Nov 15.
10
Fuzzy optimization for detecting enzyme targets of human uric acid metabolism.用于检测人类尿酸代谢酶靶标的模糊优化。
Bioinformatics. 2013 Dec 15;29(24):3191-8. doi: 10.1093/bioinformatics/btt564. Epub 2013 Sep 26.